<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Sat, 08 Aug 2026 08:34:08 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[企業] Vistagen社の社交不安症薬fasedienolの2回点鼻も有意効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110411&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110411&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 08 Aug 2026 07:50:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110411&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 嚢胞性線維症によるのではない気管支拡張症薬のPh2試験をSanofiが停止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110410&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110410&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 08 Aug 2026 07:18:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110410&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Replimuneの黒色腫薬Tudriqevを米国がとうとう承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110409&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110409&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 17:01:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110409&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Tarsus社がAlkeus社を買ってPh3試験段階のシュタルガルト病薬を手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110408&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110408&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 16:46:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110408&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] C. difficile感染を防ぐ細菌詰め合わせのPh3試験資金6000万ドルをVedantaが調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110407&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110407&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 16:12:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110407&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] LifeMind社が移植臓器拒絶予防薬LIFE-001のPh2試験資金2億6400万ドル調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110406&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110406&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 15:57:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110406&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Actimedが悪液質薬S-oxprenololの全権利を再び手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110405&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110405&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 15:37:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110405&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Modernaの季節性インフルエンザワクチンmFLUSIVAを米国FDAが承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110404&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110404&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 15:16:56 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110404&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] IDH阻害薬を経たIDH変異神経膠腫に化学放射線療法がより効く</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110403&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110403&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 13:27:51 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110403&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] バクテロイデス細菌による胆汁酸塩代謝亢進が食物アレルギーを抑制するらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110402&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110402&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 12:40:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110402&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] JAK阻害薬で移植肝臓の拒絶を解消しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110401&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110401&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 10:15:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110401&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 切除する脳腫瘍の在処を知らせ、取り零し癌細胞を死なす蛍光ナノザイムを開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110400&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110400&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 09:33:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110400&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 肩腱板損傷を悪化させる脂肪生成を線維脂肪生成前駆細胞（FAP）のDLK1が防ぐ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110399&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110399&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 07:40:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110399&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] V2a介在神経が豊富な脊髄介在神経の移植が脊髄損傷ラットに有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110398&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110398&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 07 Aug 2026 06:58:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110398&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 好中球を呼び出すガレクチン3の阻止抗体で網膜の病的血管新生を抑制しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110397&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110397&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 16:14:47 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110397&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 新型コロナウイルス感染入院患者の半数近くにウイルス再活性化が見られた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110396&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110396&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 12:14:30 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110396&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 良好な代謝と関連するFNIP1遺伝子変化を同定</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110395&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110395&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 10:24:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110395&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 成長板が傷んだ後の病的骨形成を感覚神経の阻害薬ブピバカインで防ぎうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110394&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110394&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 09:51:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110394&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Mironid社が多発性嚢胞腎薬の開発資金4600万ドル調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110393&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110393&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 08:37:56 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110393&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaとBristol Myers Squibbの交渉はないとReutersが報じた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110392&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110392&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 07:54:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110392&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Schrodinger社の人工知能(AI)科学者BunsenをBristol Myers Squibbが研究所で採用</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110391&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110391&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 07:18:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110391&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 武田薬品のナルコレプシー薬Orzeyfulを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110390&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110390&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 06 Aug 2026 06:44:16 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110390&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] NovoのCagriSemaが2型糖尿病Ph3試験の血糖値比較でLillyのtirzepatideに及ばず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110389&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110389&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 16:28:47 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110389&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] PfizerのMetseraゆかりの経口GLP-1薬MET-224oも脱落</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110388&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110388&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 15:28:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110388&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ImmunoBrain社の抗PD-L1抗体を無難に初期アルツハイマー患者に投与できた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110387&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110387&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 14:18:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110387&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ナマズの癌の伝染を発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110386&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110386&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 12:39:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110386&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Jazz社がZepzelcaの小細胞肺癌二番手治療用途取り下げ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110385&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110385&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 販売中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 10:31:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110385&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Pathos AIがAlphamab、AstraZenecaとの取り引きで乳癌薬の扱いを拡大</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110384&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110384&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 10:12:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110384&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Merck &amp; Coの抗TL1A抗体のPh2試験2つの1つが成功してもう1つが失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110383&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110383&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 09:47:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110383&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AmgenがPh1試験段階の肥満薬AMG 513の更なる開発中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110382&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110382&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 08:48:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110382&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Modernaのブンディブギョウイルスによるエボラ疾患予防ワクチンのPh1試験開始</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110381&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110381&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 05 Aug 2026 07:30:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110381&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Sethera社がReceptor.AIと組んで大環状ペプチド薬を作る</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110380&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110380&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 16:56:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110380&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 1日のうち食べないでいる時間帯を15時間以上とすることで認知機能が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110379&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110379&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 12:00:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110379&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ガが羽で匂いを嗅ぐことを発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110378&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110378&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 10:47:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110378&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] SobiのCEOがBioNTechに鞍替えして同じくCEOを務める</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110377&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110377&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 人事</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 09:43:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110377&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 放射性薬のCurium社が同業のLantheusを最大80億ドルで買う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110376&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110376&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 09:32:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110376&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaとBristol Myers Squibb（BMS）が合併交渉をしていると報じられた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110375&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110375&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 08:46:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110375&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 脳疾患治療の2社SupernusとIndiviorが合併</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110374&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110374&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 07:11:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110374&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] アトピー性皮膚炎への抗ヒスタミン薬の目ぼしい効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110373&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110373&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 04 Aug 2026 06:54:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110373&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] rivaroxabanの卵円孔開存（PFO）患者片頭痛予防がメトプロロールを凌ぐ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110372&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110372&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 17:08:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110372&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Amgenの機密情報や患者情報がハッカーに持ち出された</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110371&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110371&amp;ref=rss</guid>
		<category>ビジネス / トラブル / その他</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 16:36:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110371&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 多枝冠動脈疾患患者の低侵襲性の冠動脈バイパス手術で術後の回復が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110370&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110370&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 15:41:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110370&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Novo社のGLP-1/アミリン受容体両取り活性化薬のPh2試験で血糖値低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110369&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110369&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 14:00:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110369&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 癌の生じ易さに影響する自己抗体探し</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110368&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110368&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 12:34:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110368&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 視力を回復する無線の網膜移植製品を欧州が承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110367&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110367&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 03 Aug 2026 10:09:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110367&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 地球温暖化が西/中央アフリカのマラリア駆逐を助ける</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110366&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110366&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 02 Aug 2026 16:40:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110366&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ModernaのノロウイルスワクチンPh3試験途中解析で残念ながら有意効果示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110365&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110365&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 02 Aug 2026 15:58:16 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110365&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ホルモン感受性の前立腺癌へのNovartisの放射性薬Pluvicto使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110364&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110364&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 02 Aug 2026 09:08:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110364&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 蛋白質は少なめの方が長生きできるらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110363&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110363&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 02 Aug 2026 07:47:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110363&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Novo社のIL-6阻害薬ziltivekimabの心血管一大事を減らす効果がPh3試験で示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110362&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110362&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 01 Aug 2026 15:45:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110362&amp;ref=rss</comments>
	</item>
</channel>
</rss>
